CONMED Corp — Director's Dealing 2021

Aug 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-08-30

Reporting Person: KENNEDY JOHN JED (Group Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-30	Common Stock	M	3640	$41.93	Acquired	11015	Direct
2021-08-30	Common Stock	S	3640	$134.7501	Disposed	7375	Direct
2021-08-30	Common Stock	M	300	$59.96	Acquired	7675	Direct
2021-08-30	Common Stock	S	300	$134.75	Disposed	7375	Direct
2021-08-30	Common Stock	M	100	$78.76	Acquired	7475	Direct
2021-08-30	Common Stock	S	100	$134.75	Disposed	7375	Direct
2021-08-30	Common Stock	M	200	$97.69	Acquired	7575	Direct
2021-08-30	Common Stock	S	200	$134.75	Disposed	7375	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-30	Options To Purchase Common Stock	$41.93	M	3640	Disposed	2027-03-01	Common Stock (3640)	Direct
2021-08-30	Options To Purchase Common Stock	$59.96	M	300	Disposed	2028-03-01	Common Stock (300)	Direct
2021-08-30	Options To Purchase Common Stock	$78.76	M	100	Disposed	2029-03-01	Common Stock (100)	Direct
2021-08-30	Options To Purchase Common Stock	$97.69	M	200	Disposed	2030-03-02	Common Stock (200)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $134.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F3: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period